Observational registry for Iliac E-liac Branch Device in treating aortoiliac aneurysms

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry aims to evaluate the medium and long-term performance of the Iliac E-liac Branch Device from Artivion in treating aortoiliac aneurysms. It involves a multicentric approach, collecting data from consecutive patients who meet specific inclusion criteria. The study focuses on real-world outcomes and effectiveness of the device in a clinical setting, providing valuable insights into its use. Patients treated with the E-liac stent-graft system, either alone or in combination with other devices, will be included in the registry.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* An aortoiliac or aortic aneurysm of surgical interest based on the most recent local guidelines treated with the E-liac stent-graft system, alone or in combination with other devices

Exclusion Criteria:

* Patient's refusal to be enrolled in the registry
* Patient treated with devices not including the E-liac stent-graft system

Where it's running

• Azienda ospedaliero-universitaria consorziale policlinico di Bari
  Bari, Ba, Italy Recruiting
• Azienda Ospedaliera Universitaria Federico II
  Naples, Italy Recruiting

Study contacts

• Study coordinator: Umberto Marcello UM Bracale, PhD, Prof.
• Email: chirurgiavascolarefedericoii@gmail.com
• Phone: 081 746 2629

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• iHub Stent-Graft for Iliac Aneurysms: Safety and Performance in Endovascular Repair

  This trial tests the iHub stent-graft to see if it is safe and works well to repair iliac artery aneurysms in adults needing endovascular treatment.

  Recruiting at 2 sites Archo Medical S.A · Florianópolis, Santa Catarina and 1 other locations · NCT07005141

• Cost-helpful look at iliac branch endoprostheses in aorto-iliac aneurysm repairs

  This observational study tests the cost-effectiveness of Iliac Branch Endoprostheses in adults who undergo open or endovascular repair for aorto-iliac aneurysm.

  Recruiting IRCCS San Raffaele · Miano, Italy · NCT07096388

• Predictors of Major Adverse Limb Events After Iliac Artery Stenting

  This study tests what factors predict serious limb-related problems after iliac artery stenting in adults with peripheral artery disease.

  Recruiting I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · Milan, Mi · NCT07672249

• Using the GORE VBX balloon-expandable stent graft for covered endovascular reconstruction of the aortic bifurcation in aortoiliac occlusive disease

  This project will see if the GORE VBX balloon-expandable stent graft is safe and effective when used during covered endovascular reconstruction of the aortic bifurcation in adults treated for aortoiliac occlusive disease.

  Recruiting at 25 sites W.L.Gore & Associates · Birmingham, Alabama and 26 other locations · NCT06872905

• Comparing pain relief methods for patients undergoing vascular surgery

  This study is testing whether a single shot of a new pain medication can help people having vascular surgery feel less pain compared to the standard pain relief method.

  Recruiting Phase 4 Hartford Hospital · Hartford, Connecticut · NCT05972018

• Comparison of a new endoprosthesis to traditional stenting for iliac artery disease

  This study is testing a new type of stent for people with iliac artery disease to see if it works better than the traditional metal stents in improving blood flow and relieving symptoms.

  Recruiting at 40 sites W.L.Gore & Associates · Little Rock, Arkansas and 42 other locations · NCT05811364

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.